Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit
Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battleJohnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby powder and other talc products caused ovarian cancer, in a landmark deal that could end a contentious, decade-long legal battle.Johnson & Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, representing nearly all of the remaining talc claims against the company. Continue reading...
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.